日本国产韩国欧美黄色_国产一级大黄毛片_最近最新手机中文字幕在线看_粉嫩无码毛片免费看_日本亚洲欧美一区二区三区_国产高清网址婷婷丁香九月_888福利站高清免费视频_国产高颜值露脸在线观看_91嫩草国产线免费观看_日本护士毛茸茸的日本

Dequan Pharmaceutical (Jiangsu) Co., LTD. Hazardous waste production unit information publicity

The results of the selection of the eighth batch of state-organized centralized procurement of drugs were fully implemented

Recently, the first version of the drug catalog for people infected with COVID-19 was released, in which diclofenac sodium enteric coated sustained-release capsules were included. In order to meet the increasing market demand in the near future, Dequan Pharmaceutical (Jiangsu) Co., Ltd., located in Lujia Town, is busy in its production and packaging workshops. It tries its best to adjust the production line, increase the production capacity, and increase the horsepower to produce diclofenac sodium enteric-coated capsules.

Dequan Pharmaceuticals (Jiangsu) Co., Ltd. hereby declares that the drug substance of Gesartan produced by the company (specification: 80mg) is not used by Zhejiang Huahai Pharmaceutical Co., Ltd., so it is not affected by the recall event.

Recently, the State Food and Drug Administration issued the latest issue of the drug quality announcement (the sixth issue of the total), announcing the quality and quantity sampling inspection of 3200 batches of 21 varieties of drugs, including acyclovir eye drops, paclitaxel injection, cassia twig tuckahoe pills, lactobacillus dispersible tablets, and compound houttuynia tablets, as well as 45 batches of drugs that failed to meet the standard after inspection.

Yongxin Pharmaceuticals (1716) today announced that it passed the FDA factory inspection again with zero 483 missing. After the completion of this factory inspection, the company will continue to sell products in the United States and accept the entrustment of IMPAX and the United States Pharmaceutical Factory. The new products can also be sold in the United States market. It is expected that the company's export sales performance will also have significant growth opportunities.

At the end of 2014, the School of Public Administration of Zhejiang University, as a third-party institution, published a blue book, "Restructuring of Public Hospitals: Theory and Policy". The authors of this independent study are the team of Professor He Ziying, associate professor of the School of Public Administration of Zhejiang University, and Professor Yu Jianxing, executive vice president, and Professor Gu Xin, School of Public Administration of Peking University. These Daniel are experts in medical reform.

Surrounding Yongxin Pharmaceuticals - Hefeng 153 bus is opened to connect with Huaqiao Station of Shanghai Rail Transit Line 11. This line is the first inter-provincial subway line in China, which greatly facilitates the traffic between Kunshan and Shanghai after its opening.